Nexalin Technology’s Appointment as Industry Co-Chair of the National Traumatic Brain Injury Registry Coalition: A New Era in TBI Advocacy and Research
Houston, TX, February 10, 2025 – Nexalin Technology, Inc. (Nasdaq: NXL, NXLIW), a pioneering company in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, has recently been appointed as the Industry Co-Chair of the National Traumatic Brain Injury (TBI) Registry Coalition. This significant appointment reaffirms Nexalin’s dedication to advancing TBI advocacy and research, with a particular focus on collaborating with policymakers and stakeholders in Washington, D.C.
About the National TBI Registry Coalition
The National TBI Registry Coalition is a collaborative effort between various organizations, including government agencies, academic institutions, and industry partners, aimed at creating a comprehensive database of TBI cases. This registry will provide critical insights into the causes, treatments, and outcomes of TBIs, facilitating the development of more effective interventions and improving overall patient care.
Nexalin’s Role in the Coalition
As the Industry Co-Chair, Nexalin will contribute its expertise in DIFS technology and its potential applications in TBI treatment. This collaboration will allow Nexalin to engage with key stakeholders in the healthcare community, policymakers, and researchers, ultimately leading to increased awareness and understanding of DIFS as a promising therapeutic option for TBI patients.
Impact on Individuals
For millions of individuals living with TBI, this collaboration between Nexalin and the National TBI Registry Coalition signifies a potential turning point in their care and recovery journey. As more research is conducted and data is collected, the development of advanced treatments and interventions could lead to improved outcomes and a better quality of life for TBI patients. Additionally, increased awareness and understanding of TBI and its consequences may help reduce the social stigma surrounding the condition, leading to greater support and resources for those affected.
Impact on the World
The appointment of Nexalin as Industry Co-Chair of the National TBI Registry Coalition represents a significant step forward in the global effort to address TBI, a condition that affects millions of people worldwide. By working together with various stakeholders, Nexalin will contribute to the advancement of TBI research and advocacy, ultimately paving the way for the discovery of new and effective treatments. Furthermore, the collaboration will help raise global awareness about TBI and its impact on individuals and communities, leading to a more compassionate and supportive society for those living with this condition.
Conclusion
The appointment of Nexalin Technology, Inc. as Industry Co-Chair of the National TBI Registry Coalition marks an exciting new chapter in the realm of TBI advocacy and research. With its commitment to collaborating with policymakers, stakeholders, and researchers, Nexalin is poised to make a significant impact on the lives of millions of individuals affected by TBI. As we move forward, the potential for new treatments, increased awareness, and improved patient care is brighter than ever.
- Nexalin Technology, Inc. appointed as Industry Co-Chair of the National TBI Registry Coalition
- Focus on advancing TBI advocacy and research through collaboration with policymakers and stakeholders
- Potential for new treatments and improved patient care
- Increased awareness and understanding of TBI
- A more compassionate and supportive society for TBI patients
